ArticleGland surgery2026
Development and validation of a SEER-based prognostic nomogram for overall survival in elderly Asian American women with breast cancer.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer is the most common malignancy among Asian American women. Although Asian American patients as a group often have favorable survival outcomes, elderly Asian American women may face distinct prognostic challenges. General prognostic models for breast cancer may have reduced accuracy in elderly Asian American women, who have distinct tumor biology, treatment patterns, and social contexts. No population-specific prognostic nomogram exists for this understudied intersectional group. The present study aimed to establish and validate a prognostic nomogram to predict overall survival (OS) in elderly Asian American breast cancer patients. Methods: Cases were identified via the International Classification of Diseases for Oncology, 3 Results: Most patients had stage I disease (69.0%), hormone receptor (HR) Conclusions: This nomogram provides a tailored risk stratification tool to support clinical decision-making for elderly Asian American breast cancer patients. External validation is required to confirm its generalizability before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.